Prognostic value of cachexia index in HR +/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.
Saved in:
| Title: | Prognostic value of cachexia index in HR +/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors. |
|---|---|
| Authors: | Keskin GSY; Department of Medical Oncology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, 06018, Turkey. gulsemayildiran@gmail.com., Turgut GG; Department of Nuclear Medicine, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey., Yildirim G; Department of Medical Oncology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, 06018, Turkey., Tuzun EK; Department of Medical Oncology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, 06018, Turkey., Aslan V; Department of Medical Oncology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, 06018, Turkey., Aykan MB; Department of Medical Oncology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, 06018, Turkey., Ince S; Department of Nuclear Medicine, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey., Karadurmus N; Department of Medical Oncology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, 06018, Turkey. |
| Source: | BMC cancer [BMC Cancer] 2026 Apr 28; Vol. 26 (1). Date of Electronic Publication: 2026 Apr 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
